Scholars Central

ArticlePublished 30 Dec 2024

The Precision Mechanisms of Biologic Disease-Modifying Anti-Rheumatic Drugs (bDMARDs)

Authors: Miloslavsky M

International Journal of Clinical Rheumatology

Volume 19 · Issue 12 · Pages 352–355

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biologic Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) have revolutionized the treatment of autoimmune diseases by offering a more targeted approach compared to traditional synthetic DMARDs. By specifically modulating key molecules and pathways involved in the immune system’s inflammatory response, bDMARDs have become integral in the management of diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. The mechanistic elegance of bDMARDs lies in their precision, as they focus on inhibiting cytokines, T-cells, B-cells, and other immune factors that drive pathological inflammation. This review explores the mechanisms of action of bDMARDs, detailing how they impact immune regulation and disease progression. We also discuss the clinical benefits, challenges in their use, including issues of cost, accessibility, and resistance, and the future prospects for biologic therapies in improving outcomes for patients with autoimmune conditions.

Subjects

Rheumatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Clinical Rheumatology
  • SubjectRheumatology
  • BylineArticles whose byline prints “Miloslavsky M”